Valuation: Compumedics Limited

Market Cap 4.49Cr 3.15Cr 2.73Cr 2.55Cr 2.34Cr 4.42Cr 299.8Cr 30Cr 12Cr 149.5Cr 12Cr 12Cr 493.12Cr P/E 2026 *
15x
P/E 2027 * 6.08x
Enterprise Value 4.49Cr 3.15Cr 2.73Cr 2.55Cr 2.34Cr 4.42Cr 299.8Cr 30Cr 12Cr 149.5Cr 12Cr 12Cr 493.12Cr EV / Sales 2026 *
0.68x
EV / Sales 2027 * 0.56x
Free-Float
36.04%
Yield 2026 *
-
Yield 2027 * 8.89%
1 day+2.27%
1 week-2.17%
1 month-10.00%
3 months-20.35%
6 months-43.75%
Current year-32.84%
1 week 0.22
Extreme 0.215
0.24
1 month 0.22
Extreme 0.215
0.3
Current year 0.22
Extreme 0.215
0.45
1 year 0.22
Extreme 0.215
0.45
3 years 0.15
Extreme 0.15
0.45
5 years 0.14
Extreme 0.135
0.49
10 years 0.14
Extreme 0.135
0.96
Manager TitleAgeSince
Chief Executive Officer 67 16/12/2010
Director of Finance/CFO 61 11/11/2009
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Chairman 67 16/12/2010
Director/Board Member 61 01/01/2000
Director/Board Member - 27/10/2022
Change 5-day change 1-year change 3-year change Capi.($)
+2.27%-2.17%-36.62%+36.36% 3.16Cr
+0.38%+2.88%+23.37%+4.97% 21TCr
+0.95%+0.57%+0.08%-23.24% 14TCr
+6.13%+4.56%-22.81%+19.86% 12TCr
+4.06%+6.21%-54.74%-5.00% 6.95TCr
+1.95%+6.51%+10.44%+10.56% 4.96TCr
+6.10%+11.55%-15.77%-20.80% 4.72TCr
-0.81%+1.65%+22.05%+12.09% 3.91TCr
-2.36%+1.48%+31.90%+29.27% 3.7TCr
-2.35%+5.33%+102.73%+7.68% 3.1TCr
Average +2.08%+2.87%+6.06%+7.17% 7.48TCr
Weighted average by Cap. +2.18%+2.80%+4.44%+1.79%

Financials

2026 *2027 *
Net sales 6.63Cr 4.64Cr 4.03Cr 3.76Cr 3.46Cr 6.52Cr 442.23Cr 44Cr 17Cr 220.53Cr 17Cr 17Cr 727.39Cr 7.97Cr 5.58Cr 4.85Cr 4.53Cr 4.15Cr 7.83Cr 531.61Cr 53Cr 21Cr 265.1Cr 21Cr 20Cr 874.41Cr
Net income 38L 26.59L 23.11L 21.58L 19.81L 37.35L 25Cr 2.54Cr 99.64L 13Cr 99.88L 97.67L 42Cr 90L 62.98L 54.74L 51.1L 46.91L 88.46L 60Cr 6.03Cr 2.36Cr 30Cr 2.37Cr 2.31Cr 99Cr
Net Debt - -
Logo Compumedics Limited
Compumedics Limited is an Australia-based medical device company which is involved in the development, manufacture, and commercialization of diagnostics technology for sleep, brain and ultrasonic blood flow monitoring applications. Its geographic segments include the Americas, Australia and Asia Pacific, and Europe and the Middle East. It sells all of its product offerings in this region, including sleep diagnostic systems, clinical electroencephalograms (EEG systems), brain monitoring systems, ultrasonic blood-flow systems, supplies and technical service and support. It provides Sleep Diagnostics and Neurology Diagnostics Solutions. Its products include Compumedics Siesta, Compumedics Somfit, Compumedics Somte PSG and others. It provides a range of solutions for the neurology laboratory, from clinical epilepsy monitoring applications to Transcranial Doppler Sonography. Its other products include Grael 4K PSG, Falcon HST, Okti, Neuvo 64-512 Channel LTM EEG and others.
Employees
175
Date Price Change Volume
31/26/31 A$0.2250 +2.27% 5,811
29/26/29 A$0.2200 -8.33% 25,561
28/26/28 A$0.2400 -.--% 4,166
Trader
-
Investor
-
Global
-
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.2250AUD
Average target price
0.8000AUD
Spread / Average Target
+255.56%

Annual profits - Rate of surprise